GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orchid Pharma Ltd (NSE:ORCHPHARMA) » Definitions » Profitability Rank

Orchid Pharma (NSE:ORCHPHARMA) Profitability Rank : 4 (As of Mar. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Orchid Pharma Profitability Rank?

Orchid Pharma has the Profitability Rank of 4.

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:

1. Operating Margin %
2. Piotroski F-Score
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank

Orchid Pharma's Operating Margin % for the quarter that ended in Mar. 2024 was 29.41%. As of today, Orchid Pharma's Piotroski F-Score is 7.


Competitive Comparison of Orchid Pharma's Profitability Rank

For the Drug Manufacturers - Specialty & Generic subindustry, Orchid Pharma's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orchid Pharma's Profitability Rank Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orchid Pharma's Profitability Rank distribution charts can be found below:

* The bar in red indicates where Orchid Pharma's Profitability Rank falls into.



Orchid Pharma Profitability Rank Calculation

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Orchid Pharma has the Profitability Rank of 4.

Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.

Profitability Rank is based on these factors:

1. Operating Margin %

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Orchid Pharma's Operating Margin % for the quarter that ended in Mar. 2024 is calculated as:

Operating Margin %=Operating Income (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=638.39 / 2171.021
=29.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2. Piotroski F-Score

Good Sign:

Piotroski F-Score is 7, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

Orchid Pharma has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.

4. Consistency of the profitability

5. Predictability Rank


Orchid Pharma Profitability Rank Related Terms

Thank you for viewing the detailed overview of Orchid Pharma's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Orchid Pharma (NSE:ORCHPHARMA) Business Description

Traded in Other Exchanges
Address
313, Valluvarkottam High Road, Orchid Towers, Nungambakkum, Chennai, TN, IND, 600 034
Orchid Pharma Ltd is involved in the development, manufacturing, and marketing of diverse bulk actives, formulations, and nutraceuticals. The company operates in one business segment which is Pharmaceutical Products. The company produces various products for cardiovascular, anti-diabetic, neuropsychiatry, veterinary, non-antibiotics, and cephalosporins. The products are grouped under formulations and active pharmaceutical ingredients. The company operates its business throughout the Indian region.

Orchid Pharma (NSE:ORCHPHARMA) Headlines

No Headlines